Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amwill Health CareBOM:544353 43 14-Day RSI is 50.58 as of Sep. 07, 2026. GuruFocus rates BOM:544353 with a GF Score™ of 43/100. The stock has 3 warning signs investors should review. Among 128 Medical Distribution companies, Amwill Health Care ranks better than 50% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
Amwill Health Care (BOM:544353) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Amwill Health Care 14-Day RSI Related Terms
BOM:544353 vs MCK, COR, CAH: 14-Day RSI Comparison
For the Medical Distribution subindustry, Amwill Health Care's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amwill Health Care 14-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amwill Health Care's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Amwill Health Care's 14-Day RSI falls into.
Amwill Health Care (BOM:544353) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amwill Health Care (BOM:544353) has a 14-Day RSI of 50.58 as of Sep. 07, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Amwill Health Care and its competitors. According to the industry distribution chart, Amwill Health Care ranks #64 out of 128 companies in the Medical Distribution industry, placing it in the top 50%.
Is Amwill Health Care's 14-Day RSI too high?
Amwill Health Care's current 14-Day RSI is 50.58. The Medical Distribution industry median 14-Day RSI is 50.63. Amwill Health Care's value of 50.58 is 0.1% below this industry median. Based on the distribution chart, Amwill Health Care ranks #64 out of 128 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Amwill Health Care has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's 14-Day RSI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amwill Health Care ranks #64 out of 128 companies for 14-Day RSI. This puts Amwill Health Care in the upper half of its industry. The industry median 14-Day RSI is 50.63. Amwill Health Care's value of 50.58 is 0.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Distribution company?
The median 14-Day RSI among Medical Distribution companies is 50.63, based on 128 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amwill Health Care's current 14-Day RSI of 50.58 is 0.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Amwill Health Care and its competitors. For the Medical Distribution industry, the median 14-Day RSI is 50.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amwill Health Care's current 14-Day RSI is 50.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current 14-Day RSI of 50.58. The current 14-Day RSI is 50.58 and 0.1% below the Medical Distribution industry median of 50.63. Amwill Health Care's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current 14-Day RSI is 50.58 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
43GF Score
Get the complete analysis for BOM:544353
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544353 has been successfully added to your 
